123 related articles for article (PubMed ID: 2266681)
21. Hemodialysis-related induction of beta 2-microglobulin synthesis and release by mononuclear phagocytes.
Knudsen PJ; Shaldon S; Floege J; Koch M
Int J Artif Organs; 1990 Feb; 13(2):73-6. PubMed ID: 2112119
[TBL] [Abstract][Full Text] [Related]
22. Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes.
Paczek L; Schaefer RM; Heidland A
Nephron; 1990; 56(3):267-70. PubMed ID: 2077409
[TBL] [Abstract][Full Text] [Related]
23. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
24. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
Szepietowski T; el-Hayek A
Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
[TBL] [Abstract][Full Text] [Related]
25. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB
Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492
[TBL] [Abstract][Full Text] [Related]
26. Membrane flux not biocompatibility determines beta-2-microglobulin levels in hemodialysis patients.
Pickett TM; Cruickshank A; Greenwood RN; Taube D; Davenport A; Farrington K
Blood Purif; 2002; 20(2):161-6. PubMed ID: 11818679
[TBL] [Abstract][Full Text] [Related]
27. Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes.
Knudsen PJ; Leon J; Ng AK; Shaldon S; Floege J; Koch KM
Nephron; 1989; 53(3):188-93. PubMed ID: 2507949
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of beta 2-microglobulin in lymphocyte culture: role of hemodialysis, dialysis membranes, dialysis-amyloidosis, and lymphokines.
Campistol JM; Molina R; Bernard DB; Rodriguez R; Mirapeix E; Munoz-Gomez JM; Revert L
Am J Kidney Dis; 1993 Nov; 22(5):691-9. PubMed ID: 8238015
[TBL] [Abstract][Full Text] [Related]
29. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal blood recirculation and beta-2-microglobulin plasma levels during hemodialysis.
Di Giulio S; Splendiani G; Sturniolo A; Costanzi S; Barini A; Passalacqua S; Barbera G; Cervelli V; Cipriani G; Adorno D
ASAIO Trans; 1988; 34(3):185-7. PubMed ID: 3058172
[TBL] [Abstract][Full Text] [Related]
31. Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation.
Marchant A; Tielemans C; Husson C; Gastaldello K; Schurmans T; De Groote D; Duchow J; Vanherweghem L; Goldman M
Nephrol Dial Transplant; 1996 Apr; 11(4):657-62. PubMed ID: 8671854
[TBL] [Abstract][Full Text] [Related]
32. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes.
Sulková S; Votruba T; Lapcík O; Válek A
Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684
[TBL] [Abstract][Full Text] [Related]
33. Hemodialysis-associated platelet activation and thrombocytopenia.
Hakim RM; Schafer AI
Am J Med; 1985 Apr; 78(4):575-80. PubMed ID: 3885730
[TBL] [Abstract][Full Text] [Related]
34. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
35. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
[TBL] [Abstract][Full Text] [Related]
36. Effect of the dialysis membrane in the treatment of patients with acute renal failure.
Hakim RM; Wingard RL; Parker RA
N Engl J Med; 1994 Nov; 331(20):1338-42. PubMed ID: 7935703
[TBL] [Abstract][Full Text] [Related]
37. Potential effect of metabolic acidosis on beta 2-microglobulin generation: in vivo and in vitro studies.
Sonikian M; Gogusev J; Zingraff J; Loric S; Quednau B; Bessou G; Siffert W; Drüeke TB; Reusch HP; Luft FC
J Am Soc Nephrol; 1996 Feb; 7(2):350-6. PubMed ID: 8785408
[TBL] [Abstract][Full Text] [Related]
38. Red blood cell function and beta 2 microglobulin kinetics during cuprophan hemodialysis: a hypothesis.
Lins RL; Zachée P; Daelemans R; Vanden Broecke E; Boogaerts MA; De Broe ME
Int J Artif Organs; 1989 Oct; 12(10):638-41. PubMed ID: 2509378
[TBL] [Abstract][Full Text] [Related]
39. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane.
Combe C; Pourtein M; de Précigout V; Baquey A; Morel D; Potaux L; Vincendeau P; Bézian JH; Aparicio M
Am J Kidney Dis; 1994 Sep; 24(3):437-42. PubMed ID: 8079969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
